Logo.png
Guardion Health Sciences, Inc. Announces Proposed Public Offering
17 févr. 2022 09h00 HE | Guardion Health Sciences, Inc.
HOUSTON, TEXAS, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported...
Logo.png
Guardion Provides Answers to Frequently Asked Questions Regarding the Reasons for Approving the Reverse Stock Split Proposal at Upcoming 2020 Annual Stockholders’ Meeting
27 oct. 2020 08h30 HE | Guardion Health Sciences, Inc.
SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) is providing the following answers to frequently asked questions to its...
Logo.png
Guardion Provides Answers to Frequently Asked Questions Regarding the Reasons for Approving the Reverse Stock Split Proposal at Upcoming 2020 Annual Stockholders’ Meeting
27 oct. 2020 08h30 HE | Guardion Health Sciences, Inc.
SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) is providing the following answers to frequently asked questions to its...
Logo.png
Guardion Announces Virtual Annual Meeting of Stockholders
11 sept. 2020 17h20 HE | Guardion Health Sciences, Inc.
Annual stockholder meeting scheduled for Thursday, October 29, 2020 San Diego, California, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc.(“Guardion” or the...
Logo.png
Guardion Subsidiary VectorVision Receives Approval from Korean Intellectual Property Office for CSV-2000 Trademark
15 juil. 2020 09h00 HE | Guardion Health Sciences, Inc.
The Only Computer Vision Testing Device to Combine Standardized Contrast Sensitivity Testing with a Full Suite of Clinical Vision Tests San Diego, California, July 15, 2020 (GLOBE NEWSWIRE) --...
Logo.png
Guardion Health Sciences Announces Submission of Patent Application for Treatment of Certain Underlying Conditions Related to Eye Disease
08 juil. 2020 08h45 HE | Guardion Health Sciences, Inc.
Patent Application Will Add to Guardion’s Intellectual Property Portfolio San Diego, California, July 08, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”)...
Logo.png
Guardion Health Sciences Names Dr. David Evans as Interim President and Interim Chief Executive Officer
15 juin 2020 16h20 HE | Guardion Health Sciences, Inc.
San Diego, California, June 15, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced today that its Board of Directors has appointed Dr....
Logo.png
Guardion Health Sciences Reports First Quarter 2020 Financial Results and Provides Corporate Update
14 mai 2020 07h00 HE | Guardion Health Sciences, Inc.
— 40% increase in medical foods revenue in the first quarter compared to the same period last year — Launch of immuno-supportive/antioxidant complex, acuMMUNE™ — Growing portfolio of synergistic...
Logo.png
Lumega-Z® Demonstrates Superiority in a Head-to-Head Study Showing Better Bioavailability of Carotenoids and Restoring Macular Pigment Density
12 mai 2020 07h05 HE | Guardion Health Sciences, Inc.
-- First study to provide a head-to-head comparison of two commercially available supplements with regard to the changes in serum levels of carotenoids, visual function and macular pigment optical...
Logo.png
Guardion Health Sciences to Present at the April 2020 Virtual Investor Summit
15 avr. 2020 09h05 HE | Guardion Health Sciences, Inc.
– Presentation with live audio webcast on Wednesday, April 22 at 1:30 PM ET, immediately followed by an interactive Q&A session – San Diego, California, April 15, 2020 (GLOBE NEWSWIRE)...